
|Articles|June 14, 2007
ADHD pharmacotherapy: Prescribe with safety in mind and monitor results with vigilance
The keys to optimal use of psychostimulant and nonstimulant medications for attention deficit hyperactivity disorder are careful screening of patients, appropriate dosage regulation, and?most of all?close monitoring of both positive and adverse outcomes.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy
2
Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults
3
Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings
4
Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis
5











